Novel Imaging Agent Safe in Airway Disease Patients, Clinical Data, Inc.
MedPageToday -- PHILADELPHIA -- A novel pharmacologic stress agent for myocardial perfusion imaging, apadenoson (Stedivaze), was well tolerated in patients with asthma and chronic obstructive pulmonary disease (COPD), a phase I study showed.